Ivan Bergstein, Chief Executive Officer, 10% Owner at STEMLINE THERAPEUTICS INC (STML), bought 2,000 shares at $11.05 ($22K) on 2014-09-03, disclosed to the SEC on 2014-09-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| STML | SELL | 2020-02-28 | $316K | — | Filing → |
| STML | SELL | 2020-01-03 | $987K | — | Filing → |
| STML | SELL | 2019-08-16 | $1.0M | — | Filing → |